Statins are essential medications in the management of patients with clinical atherosclerotic cardiovascular disease, and have been supported by numerous clinical trials. Emerging evidence suggests that adding ezetimibe to statin therapy is associated with a net benefit and improved hard clinical outcomes, particularly in patients with significantly elevated atherosclerotic cardiovascular disease risk and elevated low-density lipoprotein cholesterol levels.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccl.2017.12.003 | DOI Listing |
Publication Analysis
Top Keywords
atherosclerotic cardiovascular
8
cardiovascular disease
8
optimizing statins
4
statins ezetimibe
4
ezetimibe guideline-focused
4
guideline-focused management
4
management statins
4
statins essential
4
essential medications
4
medications management
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!